β-hydroxy-β-methylbutyrate suppresses NF-ĸB activation and IL-6 production in TE-1 cancer cells

6Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Stress reactions, especially those related to surgery, cause poor convalescence of cancer patients. β-Hydroxyβ-methylbutyrate (HMB) is known to regulate excessive inflammation in the body. The objective of this work was to investigate the capacity of HMB to suppress activation of nuclear factor-kappa B (NF-ĸB) and production of interleukin-6 (IL-6) in a human esophageal squamous cell carcinoma cell line (TE-1). Materials and Methods: Cell proliferation was measured using the water-soluble tetrazolium-1 method, while tumor necrosis factor alpha (TNFα)-induced IL-6 production was measured using an enzyme-linked immunosorbent assay (ELISA) assay. Nuclear translocation of NF-ĸB was detected by immunofluorescence staining. Results: HMB did not affect cell proliferation. However, HMB suppressed the TNFα-induced increase in IL-6 production in TE-1 cells by inhibiting NF-ĸB activation. Conclusion: HMB did not influence TE-1 cell proliferation, but inhibited activation of NF-ĸB and IL-6 production. This result may be useful for improving excessive stress reactions during and after surgery.

Cite

CITATION STYLE

APA

Miyake, S., Ogo, A., Kubota, H., Teramoto, F., & Hirai, T. (2019). β-hydroxy-β-methylbutyrate suppresses NF-ĸB activation and IL-6 production in TE-1 cancer cells. In Vivo, 33(2), 353–358. https://doi.org/10.21873/invivo.11481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free